Johnson & Johnson buys drugmaker Momenta for $6.5 billion
Wednesday, August 19, 2020 - 08:00
in Mathematics & Economics
U.S. pharma company Johnson & Johnson announced Wednesday it will buy drugmaker Momenta in a $6.5 billion deal, as it seeks to expand its presence in the autoimmune diseases market.